PGY1 Pharmacy South Sacramento, California

The PGY1 Residency Program at Kaiser Permanente South Sacramento follows guidelines set by the American Society of Health-System Pharmacists and provides thorough training in a variety of specialties.

PGY1 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.

---

Pharmacy Services

The pharmacy department in the South Sacramento Service Area strives to provide world-class pharmaceutical care in a professional and supportive environment. The pharmacy department has a commitment to teaching and training interns, students, and residents. Our outpatient pharmacies are supported by a high-tech automated drug refill pharmacy and a centralized call processing center, both located in Livermore, California. This allows our outpatient pharmacists to focus on performing clinical checking and patient counseling. The inpatient pharmacists at our Level II trauma center work collaboratively with physicians and nurses to provide drug therapy recommendations, dosing per pharmacy protocol (includes anticoagulation, vancomycin and aminoglycosides, TPN dosing adjustments), medication therapy monitoring and patient education. Intensive care unit and infectious disease (ID) pharmacists round with the critical care and ID teams. Clinical pharmacists in ambulatory care work autonomously under collaborative practice protocols. Our ambulatory care pharmacy services include hospice, chronic pain management, cardiovascular risk reduction (@Goal), medication therapy management (MTM), HIV, psychiatry, geographic managed care (GMC), and oncology.

South Sacramento At A Glance

---

Learning Experiences

Required Learning Experiences

• Outpatient Medication Quality Improvement Pharmacy
• Internal medicine
• Infectious disease (ID)
• Cardiovascular Risk Reduction (@Goal)
• Outpatient pharmacy practice
• Inpatient pharmacy practice
• Pharmacy APPE student precepting
• Pharmacy administration
• Drug utilization management

Required Longitudinal Learning Experiences

• Lead resident program
• Research project

Elective Learning Experiences

Inpatient

• Critical Care/Trauma
• Advanced Critical Care

Ambulatory Care

• HIV
• Psychiatry
• MediCaid Care Coordination Program (MCC)
• Chronic pain
• Oncology
• Regional pharmacy continuum (located in San Leandro and Oakland)

---

Requirements for Acceptance

• Must be licensed as an Intern Pharmacist in the state of California by the first day of residency program.
• Resident must be a licensed California pharmacist within 120 days from the program start date. Residents who are not licensed as a pharmacist within 120 days from the program start date will have their term of appointment extended by the number of days the resident is without licensure past the 120-day deadline up to a maximum of 45 days. Failure to obtain a California state pharmacist license within 165 days from the program start date will result in the resident being dismissed from the program and employment will be terminated.
• To be eligible for pharmacist licensure, candidates must be graduates or candidates for graduation from an ACPE accredited degree program (or one in the process of pursuing accreditation) or have a Foreign Pharmacy Graduate Examination Committee (FPGEC) certificate from the NABP.
• For more information regarding licensing in California, please visit www.pharmacy.ca.gov
• Certifications (If applicable): BLS, ACLS
• Candidates must be registered in the National Matching Services, Inc. (NMS).
• Candidates must participate in the ASHP Matching Program.
• Program NMS Code: 176513 and ASHP Program Code: 92020

---

Application Requirements

• Statement of Interest/Letter of Intent
• Curriculum Vitae
• Official Pharmacy School transcripts, sent directly from the applicant’s college or school of pharmacy
• Three letters of references/recommendations utilizing the form in PhORCAS is required for all reference writers.
• Phase II Application Deadline: March 27, 2025

---

Interview Details

• On-Site or Virtual Interview Required
• Interview Dates: Approximately Mid February
• Click here to link to the Virtual Information Session:
  • November 20, 2024 – 11a.m. – 12p.m. PST

**This residency agrees that no person at this residency will solicit, accept, or use any ranking-related information from any residency applicant**

Back to all programs